首页> 外文期刊>Radiological physics and technology >Characteristic X-ray imaging for palliative therapy using strontium-89 chloride: understanding the mechanism of nuclear medicine imaging of strontium-89 chloride
【24h】

Characteristic X-ray imaging for palliative therapy using strontium-89 chloride: understanding the mechanism of nuclear medicine imaging of strontium-89 chloride

机译:使用锶-89氯化物的姑息治疗特征X射线成像:了解锶-89氯化物核医学成像的机制

获取原文
获取原文并翻译 | 示例
           

摘要

Strontium-89 (Sr-89) chloride is a targeted palliative therapy used for painful bone metastasis in which repeated doses can be administered, and its usefulness has been reported in the case of bone metastasis of various primary tumors. However, the effectiveness of the pain relief treatment is only described using a subjective index such as the visual analog scale, which lacks objectivity. Although various attempts at quantifying the effectiveness of Sr-89 chloride therapy have been reported using nuclear medicine imaging for energy peaks around 70-80 keV, the principle of Sr-89 chloride imaging has not been explained. In this study, the principle of nuclear medicine imaging for Sr-89 chloride was evaluated using a fundamental study. Additionally, the optimal collimator for acquiring Sr-89 chloride image data was evaluated.
机译:氯化锶-89(SR-89)氯化物是用于疼痛的骨转移的靶向姑息治疗,其中可以给予重复剂量,并且在各种原发性肿瘤的骨转移的情况下已经报道了其有用性。 然而,仅使用诸如视觉模拟规模的主观索引来描述疼痛缓解处理的有效性,这些索引缺乏客观性。 尽管使用核医学成像来定量SR-89氯化物疗法的有效性的各种尝试,但核医学成像约为70-80KeV,但尚未解释SR-89氯化物成像的原理。 在这项研究中,使用基本研究评估了SR-89氯化物的核医学成像原理。 另外,评估用于获取SR-89氯化物图像数据的最佳准直器。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号